sb 203580 has been researched along with Carcinoma, Anaplastic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, Z; Fan, Q; Wang, F; Wang, L | 1 |
| Kumar, S; Liou, JP; Pai, HC; Pan, SL; Shen, CC; Teng, CM | 1 |
| Hwang, HS; Jittreetat, T; Kim, CH; Kim, YS; Lee, BS; Sannikorn, P; Shin, YS | 1 |
| Behren, A; Iftner, T; Mühlen, S; Plinkert, PK; Simon, C | 1 |
| Bueno, AL; Goemann, IM; Maia, AL; Meyer, EL; Romitti, M; Wajner, SM; Zennig, N | 1 |
| Blaschke, F; Bruemmer, D; Herle, AJ; Hsueh, WA; Law, RE; Yin, F | 1 |
| Ben-Ze'ev, A; Kosakowski, M; Lee, P; Libertino, JA; Moinzadeh, A; Rieger-Christ, KM; Stoffel, J; Summerhayes, IC; Zagha, R | 1 |
| Okajima, E; Thorgeirsson, UP | 1 |
| Boucher, MJ; Lainé, J; Morisset, J; Reed, JC; Rivard, N; Vachon, PH | 1 |
| Bacus, SS; Gudkov, AV; Keyomarsi, K; Komarov, AP; Lowe, M; Lyass, L; Seger, R; Yarden, Y; Yung, Y | 1 |
10 other study(ies) available for sb 203580 and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Epigallocatechin‑3‑gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metalloproteinase‑2.
Topics: Anticarcinogenic Agents; Carcinoma; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enzyme Activation; Female; Humans; Imidazoles; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Biosynthesis; Pyridines | 2014 |
MT-4 suppresses resistant ovarian cancer growth through targeting tubulin and HSP27.
Topics: Animals; Antineoplastic Agents; Aurora Kinase B; Benzyl Compounds; Carcinoma; Caspase 3; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin B; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; Histones; HSP27 Heat-Shock Proteins; Humans; Imidazoles; Mice; Molecular Chaperones; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pyridines; Signal Transduction; Tubulin; Tubulin Modulators; Xenograft Model Antitumor Assays | 2015 |
Tolfenamic Acid Inhibits the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma: Involvement of p38-Mediated Down-Regulation of Slug.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Gastropoda; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Imidazoles; MAP Kinase Signaling System; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; ortho-Aminobenzoates; Phosphorylation; Pyridines | 2016 |
AP-1 and ERK1 but not p38 nor JNK is required for CRPV early protein 2-dependent MMP-9 promoter activation in rabbit epithelial cells.
Topics: Animals; Anthracenes; Binding Sites; Carcinoma; Cell Line; Cell Line, Tumor; Cottontail rabbit papillomavirus; Disease Models, Animal; DNA Mutational Analysis; Enzyme Inhibitors; Epithelial Cells; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 3; Molecular Sequence Data; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Pyridines; Rabbits; Signal Transduction; Transcription Factor AP-1; Transcription Factors; Viral Proteins | 2009 |
Increased type 3 deiodinase expression in papillary thyroid carcinoma.
Topics: Adult; Butadienes; Carcinoma; Carcinoma, Papillary; Cell Line, Tumor; Child; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Immunohistochemistry; Iodide Peroxidase; Male; MAP Kinase Signaling System; Middle Aged; Mutation; Nitriles; Proto-Oncogene Proteins B-raf; Pyridines; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Transforming Growth Factor beta1; Young Adult | 2012 |
Signaling pathways involved in induction of GADD45 gene expression and apoptosis by troglitazone in human MCF-7 breast carcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Cell Cycle; Chromans; Enzyme Inhibitors; Female; Flavonoids; GADD45 Proteins; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Proteins; Pyridines; RNA, Small Interfering; Signal Transduction; Thiazolidinediones; Troglitazone; Tumor Cells, Cultured | 2004 |
Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway.
Topics: Blotting, Western; Cadherins; Carcinoma; Cell Line, Tumor; Chromones; Clone Cells; Collagen; Drug Combinations; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; Imidazoles; Immunohistochemistry; Laminin; Morpholines; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proteoglycans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Pyridines; Serine; Signal Transduction; Transfection; Urinary Bladder Neoplasms | 2004 |
Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells.
Topics: Animals; Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma; Cell Line; Cell Transformation, Neoplastic; Endothelial Growth Factors; Epithelial Cells; Flavonoids; Genes, myc; Genes, ras; Imidazoles; Liver; Lymphokines; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Oncogene Proteins v-raf; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Retroviridae Proteins, Oncogenic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells.
Topics: Apoptosis; bcl-X Protein; Carcinoma; Caspases; Cell Cycle; Cell Survival; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Enzyme Activation; Enzyme Inhibitors; Flavonoids; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; MAP Kinase Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Multienzyme Complexes; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerases; Prostaglandin-Endoperoxide Synthases; Proteasome Endopeptidase Complex; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Pyridines; Tumor Cells, Cultured | 2000 |
Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Carcinoma; CDC2-CDC28 Kinases; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Enzyme Inhibitors; Female; Flavonoids; G2 Phase; Humans; Imidazoles; MAP Kinase Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Mitosis; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Protein Serine-Threonine Kinases; Pyridines; Rats; Receptor, ErbB-2; Retinoblastoma Protein; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |